免疫性细胞死亡的调节和癌症治疗中的潜在应用
Kun Fang1,2, Shuai Yuan1,2, Xue Zhang1,2
1Central Laboratory, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University (Liaoning Cancer Hospital & Institute), Shenyang, Liaoning, China.
Frontiers in immunology
|April 10, 2025
概括
免疫性细胞死亡 (ICD) 对适应性免疫非常重要. 本综述详细介绍了ICD诱导剂,机制和多模式免疫疗法,以增强抗瘤效果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 免疫性细胞死亡 (ICD) 是一种受调节的细胞死亡途径,可刺激自适应性免疫反应.
- ICD的主要特征包括卡莱蒂库林暴露,热冲击蛋白释放,ATP分泌和HMGB1释放.
- 了解ICD对于开发有效的癌症免疫疗法至关重要.
研究的目的:
- 审查和分类新的ICD诱导剂及其分子机制.
- 讨论ICD诱导通过化疗,向药物和瘤病毒的临床应用.
- 探索表观遗传修饰剂和物理刺激在多模式免疫疗法中的作用.
主要方法:
- 文献综述和对ICD当前研究的综合.
- ICD诱导剂及其作用机制的分类.
- 分析多模式免疫疗法策略中的协同效应.
主要成果:
- 总结了最新的ICD诱导剂,并对它们的分子机制进行了分类.
- 讨论了用于ICD诱导的化疗,向药物和瘤病毒的临床研究.
- 研究了物理刺激与ICD诱导剂相结合的协同抗瘤效应.
结论:
- ICD在激活抗瘤免疫反应方面发挥着重要作用.
- 结合ICD诱导与物理治疗的多模式方法显示出协同作用的潜力.
- 对ICD机制的进一步了解可以指导新型免疫疗法的开发.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
The Extrinsic Apoptotic Pathway
5.5K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.5K
Cytotoxic T Cells-mediated Immune Response
740
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
740
The Intrinsic Apoptotic Pathway
5.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.7K
Regulation of the Unfolded Protein Response
2.3K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.3K


